A detailed history of Gf Fund Management Co. Ltd. transactions in Annexon, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,843 shares of ANNX stock, worth $8,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,843
Previous 2,364 20.26%
Holding current value
$8,130
Previous $7.21 Million 97.95%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 26, 2026

BUY
$2.68 - $3.54 $1,283 - $1,695
479 Added 20.26%
2,843 $14.3 Million
Q3 2025

Nov 06, 2025

SELL
$2.05 - $3.37 $748 - $1,230
-365 Reduced 13.37%
2,364 $7.21 Million
Q1 2025

Apr 28, 2025

BUY
$1.93 - $5.5 $947 - $2,700
491 Added 21.94%
2,729 $5.27 Million
Q4 2024

Feb 18, 2025

BUY
$4.44 - $7.63 $9,936 - $17,075
2,238 New
2,238 $11.5 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $136M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.